³Ô¹ÏÍøÕ¾

Latest clinical trial News | Page 6

Moderna launches regional research centre and headquarters to advance mRNA research
Biotron completes clinical phase of BIT225 COVID-19 clinical trial
Imugene licenses allogeneic CAR-T with a potential registration study in 2024
From bed bound to marathon runner
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Dimerix announces successful completion of second DSMB review of ACTION3 trial
$2.7 million in MRFF grants for MS research and maternity studies
NSW’s pharmacy trial expands statewide starting Monday
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Daily aspirin doesn’t prevent strokes in older, healthy people after all
Study shows ultra-low-dose 4-in-1 blood pressure pill would be cost-effective in Australia
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
Dimerix updates on expected timing of DMX-200 Phase 3 kidney trial outcome
Monash expert: New Nature Medicine study into the use of psychedelic substance, psilocybin, for the treatment of anorexia nervosa
One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
Ketamine effective for treatment-resistant depression: clinical trial
Researchers look to arrest the development of Type 1 diabetes in children More children are getting Type 1 diabetes and Mater Researcher…
$5.5 million for research to reduce impact of loneliness on chronic disease
Sleep for bushfire survivors. Cane waste to rebuild soil health. The real carbon cost of your travel. Creating tri-sector careers
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
Improving patient outcomes for kidney transplants
Major funding boost for phage therapy manufacturing in NSW
New data supports current management of CO2 levels in cardiac arrest patients
Update on MDMA and psilocybin access and safeguards from 1 July 2023
Trial finds vitamin D supplements could prevent heart attacks in over 60s
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
New psychedelic-assisted therapy trial aims to help cancer patients
Putting research in frame
Award-winning therapy brings light into darkness
Major Boost Into Childhood Cancer Research
Emerging health and medical research leaders are solving health problems and improving health care
PreBabe trial examines benefits of losing weight preconception
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
ARC Research Hub to transform biopharmaceutical manufacturing
Aravax launches new Phase 2 trial of peanut allergy candidate
The economics of it just won’t work – and it’ll be terrible for the environment: Australia’s leading expert on cell-based meat speaks…
World-first trial for paediatric brain cancer right here in NSW
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
The FDA finally approved Elon Musk’s Neuralink chip for human trials. Have all the concerns been addressed?
Benefits of creatine: safer birth for mum and baby
Financial boost for life-saving transplant treatment in WA
Existing drugs could treat strokes linked to dementia
New life changing treatment for dwarfism added to pbs
Avecho Biotechnology commences manufacturing for Phase 3 insomnia study
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
Trial of Android artificial pancreas system for adults with type 1 diabetes
Chimeric Therapeutics announces new capital raise